ICPA launches antibiotic for Dental treatment

The product composition is Amoxycillin 500mg + Clavulanic acid 125mg and is approved by the DCGI.

Health Teeth, Dental
Picture: Pixabay

ICPA Health Products (ICPA), a pharma company leading in the oral-health segment has launched ICPAMOX – CV 625 meant to treat odontogenic infections.

The product is an antibiotic with a broad-spectrum activity against the commonly occurring bacterial pathogens in the oral cavity and other parts of the body.

An antibiotic indicated in multiple conditions, ICPAMOX – CV 625 is recommended for use along with dental treatments like root canal, tooth extractions and various oral surgeries to reduce post-operative infection.

The product composition is Amoxycillin 500mg + Clavulanic acid 125mg and is approved by the DCGI.

Also read | Supreme Court imposes 5 Cr fine on UP Medical College

“The launch of ICPAMOX – CV 625 is a testament to our focus in the oral health care segment. ICPAMOX – CV 625 marks our foray into antibiotics and we plan to introduce more products in the segment.

The product is extremely effective for treating odontogenic infections in patients undergoing various types of dental treatments,” said Abha Damani, Director, ICPA.

ICPA are the manufacturers of brands like Thermoseal and Hexidine in the oral health-care segment and are also present in the dermatology, haemorrhoids and ENT segments.

A box of ICPAMOX – CV 625 is available at an MRP of Rs 189/- and contains 10 tablets.

Also read:

Zydus Cadila gets USFDA nod for Anti Depressant drug

Granules gets USFDA nod for Acetaminophen, Aspirin and Caffeine tablets

Strides gets USFDA Yes for Ibuprofen OTC Oral Suspension

Sun Pharma to launch entire range of Epilepsy treatment drug in India

Dr Reddy’s launch Lansoprazole DR orally disintegrating tablets

Unichem gets USFDA approval for Apremilast Tablets

The Health Master is now on Telegram. For latest update on health and Pharmaceuticals, subscribe to The Health Master on Telegram.

Go to main website, click here

Follow and connect with us on Facebook and Linkedin

Subscribe for daily free updates, click here

For daily free updates on WhatsApp, click here

Subscribe here for daily updates